Clinical trial · Observational
Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer
Phase 1 of Serum IGF II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer
NCT01371695CI-TRIAL-00005008unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether Insulin-like Growth Factor II is elevated sufficiently to detect Cervical Intraepithelial Neoplasia II (CIN II), Cervical Intraepithelial Neoplasia III (CIN III), and cervical cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Cervical Intraepithelial Neoplasia II | — | UNRESOLVED | — |
| Cervical Intraepithelial Neoplasia III | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 - 75 years * Female * Normal medical history * Medical history of a single type of cancer confirmed by biopsy or equivalent criteria * Squamous cell carcinoma of organs other than cervix * Adenocarcinoma * Medical history of inflammatory disease * May be pregnant * Pap smear positive for Cervical Intraepithelial Neoplasia II or III * Squamous cell cervical cancer confirmed by biopsy * Informed consent * Willingness to submit a blood sample by venipuncture * Willingness to submit a second blood sample if necessary Exclusion Criteria: * Age \< 18 or \> 75 years * Medical history of cancer other than cervical cancer, Non-islet-cell tumor hypoglycemia, Growth hormone deficiency, Acromegaly, Hepatoma, inflammatory disease in addition to confirmed CIN and cervical cancer
References
Publications (0)
Data not yet available
No reference posted for this study.